ASTRID
LIVE

Serial Number

79434747

Owner

PeriCard Check GmbH

Attorney

Ashley M. Robinson

Filing Date

Sep 5, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ASTRID Trademark

Serial Number: 79434747

ASTRID is a trademark filed by PeriCard Check GmbH on September 5, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

PeriCard Check GmbH

Schwachhauser Heerstraße 59

Entity Type: 16

Trademark Details

Filing Date

September 5, 2025

Registration Date

Not Registered

Published for Opposition

September 29, 2026

Goods & Services

Diagnostic preparations for medical purposes; diagnostic preparations and materials in the nature of diagnostic reagents, diagnostic antibody reagents or antibodies, monoclonal antibodies and buffer solutions for use in in vitro diagnostics, reagents for use in in vitro diagnostics, and medical diagnostic test strips for blood analysis, all for medical and veterinary purposes; chemical, biochemical and biological preparations, namely, chemical reagents for medical purposes, biochemical reagents for medical purposes; chemical and biochemical preparations, namely, diagnostic reagents, diagnostic antibody reagents or antibodies, monoclonal antibodies and buffer solutions for use in in vitro diagnostics, and reagents for use in in vitro diagnostics, all for veterinary purposes; biological preparations, namely, diagnostic reagents, diagnostic antibody reagents or antibodies, monoclonal antibodies and buffer solutions for use in in vitro diagnostics, and reagents for use in in vitro diagnostics, all for veterinary purposes; clinical diagnostic reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; diagnostic biomarker reagents for medical or veterinary purposes; diagnostic preparations for medical purposes used by medical laboratories; medical diagnostic test strips for blood analysis; diagnostic test kits consisting primarily of diagnostic reagents, antibody reagents or antibodies, buffers, and reagents, for use in in vitro diagnostics, and test strips for blood analysis for disease testing; in vitro diagnostic agents for medical use; in-vitro diagnostics for veterinary purposes; diagnostic test kits for medical purposes consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents, for use in in vitro diagnostics, and test strips for blood analysis disease testing; diagnostic test kits for veterinary purposes consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for blood analysis for disease testing; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for blood analysis for disease testing for medical purposes; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for blood analysis for disease testing for veterinary purposes; medical diagnostic test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for detecting acute aortic syndrome; diagnostic test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for detecting aortic dissection; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostic apparatus, and test strips for detecting acute aortic syndrome; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for detecting aortic dissection; diagnostic test kits consisting primarily of diagnostic reagents, antibody reagents or antibodies, monoclonal antibodies, buffer solutions, reagents and test strips for blood analysis, all for use in in vitro diagnostics for diagnosing the recurrence or progression of disease in patients following surgery; diagnostic test kits consisting primarily of diagnostic reagents, antibody reagents or antibodies, monoclonal antibodies, buffer solutions, reagents and test strips for blood analysis, all for use in in vitro diagnostics for diagnosing the recurrence or progression of cardiovascular disease in patients following cardiological interventions; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents or antibodies, monoclonal antibodies, buffer solutions, reagents, and test strips for blood analysis, all for use in in vitro diagnostics for diagnosing the recurrence or progression of disease in patients following surgery; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents or antibodies, monoclonal antibodies, buffer solutions, reagents and test strips for blood analysis, all for use in in vitro diagnostics for diagnosing the recurrence or progression of cardiovascular disease in patients following cardiological interventions and surgery.

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 1, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 7, 2026 TROA
REFUSAL PROCESSED BY IB
Mar 5, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 18, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 18, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 24, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 23, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 21, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 16, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 16, 2025 REPR